Jenny X. Hu

Family Medicine

800 Prudential Dr
Jacksonville, FL 32207

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 5 publications

Efficacy and Safety of Therapies for Systemic Sclerosis-Associated Interstitial Lung Disease: A Bayesian Network Meta-Analysis.

Efficacy and Safety of Therapies for Systemic Sclerosis-Associated Interstitial Lung Disease: A Bayesian Network Meta-Analysis.

Journal: Annals of the American Thoracic Society

Published: March 09, 2026

Effects of Methylnaltrexone on Ticagrelor-Induced Antiplatelet Effects in Coronary Artery Disease Patients Treated With Morphine.

Effects of Methylnaltrexone on Ticagrelor-Induced Antiplatelet Effects in Coronary Artery Disease Patients Treated With Morphine.

Journal: JACC. Cardiovascular interventions

Published: March 01, 2019

Pharmacodynamic Comparison of Prasugrel Versus Ticagrelor in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease: The OPTIMUS (Optimizing Antiplatelet Therapy in Diabetes Mellitus)-4 Study.

Pharmacodynamic Comparison of Prasugrel Versus Ticagrelor in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease: The OPTIMUS (Optimizing Antiplatelet Therapy in Diabetes Mellitus)-4 Study.

Journal: Circulation

Published: May 09, 2016

Pharmacodynamic Effects of Switching From Prasugrel to Ticagrelor: Results of the Prospective, Randomized SWAP-3 Study.

Pharmacodynamic Effects of Switching From Prasugrel to Ticagrelor: Results of the Prospective, Randomized SWAP-3 Study.

Journal: JACC. Cardiovascular interventions

Published: February 19, 2016

Crushed Prasugrel Tablets in Patients With STEMI Undergoing Primary Percutaneous Coronary Intervention: The CRUSH Study.

Crushed Prasugrel Tablets in Patients With STEMI Undergoing Primary Percutaneous Coronary Intervention: The CRUSH Study.

Journal: Journal of the American College of Cardiology

Published: January 30, 2016

Showing 1-5 of 5

Last Updated: 09/26/2026